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BACKGROUND: Obesity is an important cardiovascular risk factor and associated with low grade inflammation in chronic kidney disease 
(CKD) patients. This study aims to assess the association 
between body fat with serum high sensitivity C-reactive 
protein (hs-CRP) level in CKD patients.
METHODS: A cross-sectional study was performed in 71 
CKD  patients.  Anthropometric  measurements  included 
body weight, height, body mass index (BMI), body fat 
percentage (BFP), skinfold thickness (SKF) of triceps 
and biceps were performed by trained physician. BFP 
was calculated using Kwok’s Formula and hs-CRP was 
measured by Particle enhanced Turbidimetry.
RESULTS:  The averaged BMI of our subjects was 
25.8±4.4. There was no significant difference in BMI 
between pre-dialysis and hemodialysis CKD patients. 
Positive correlation was found between BFP and hs-CRP 
(r=0.266; p<0.05), while there was no significant correlation 
between BMI and hs-CRP.
CONCLUSION: Body fat percentage was associated 
with hs-CRP. Hence, it will be more beneficial to assess 
nutritional status in CKD using BFP rather than BMI alone 
since it was demonstrated to correlate with hs-CRP in our 
study.
KEywORDS:  CKD,  obesity,  inflammation,  body  fat, 
hs-CRP
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Abstract
Introduction
In  last  decades,  chronic  kidney  disease  (CKD) has been 
one of the global health problems with high morbidity and 
mortality rates. The prevalence of CKD in United States was 
around 6-10% of adult population with mortality rate 20-
50%.(1) In Indonesia, the prevalence of CKD was 10%.(2) 
Chronic kidney disease is a progressive disease with wide 
spectrum of manifestations, from mild decreased kidney 
function denoted by micro albuminuria to chronic renal 
failure  with  necessity  for  renal  replacement therapy.(3)  
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 Obesity is an important CKD risk factor with high 
prevalence in general population.(4,5). Study by Kelly, et 
al., estimated 937 million or 23.2% of the world’s adult 
population was overweight  and 396 million (9.8%) was 
obese.(6,7) They also projected the absolute numbers of 
overweight and obese individuals in 2030 will increase to 
be 2.16 billion and 1.12 billion, respectivley.(7) In 2010, 
overweight and obesity were estimated to cause 3.4 million 
deaths, 3.9 % of years of life lost, and 3.8 % of disability-
adjusted life-years (DALYs) worldwide.(8) Available 
data show that the most dramatic increases in obesity are 
in developing  countries  such as  Mexico,  China,  and 
Thailand.(9,10)
 Inflammation is considered as one of the key elements 
in almost all of kidney diseases. In CKD, particularly in 
patients with end-stage renal disease (ESRD), prevalence 
of chronic low-grade inflammation is quite high. One of 
the potential causes of low-grade inflammation in CKD 
patients is excess of adipose tissue. Recently, adipose 
tissue is  considered   as   an  endocrine  organ  and  major 
site  that  plays  important  role  for  inflammatory  and 
metabolic pathways.(11) The adipose tissue is a complex 
organ with functions other than energy storage, and secretes 
several adipokines, such as tumor necrosis factor (TNF)-α, 
interleukin (IL)-6, type 1 plasminogen activator inhibitor 
(PAI-1), C-reactive Protein (CRP), resistin, and acylation-
stimulating protein.(12) In the human body, the major fat 
deposit sites are subcutaneous fat and visceral abdominal 
fat. Both of the fat deposit sites stated previously are 
associated with insulin resistance and pro inflammation in 
obese subjects.(11)
 Excess of adipose tissue and chronic inflammation 
are associated with early pathogenesis of kidney injury, 
such as glomerular hyperfiltration. Moreover, a harmful 
renal hemodynamic  profile  is  also  linked  to  obesity 
both in patients with ESRD and general population. Patients 
with advanced CKD had increased expression of pro-
inflammatory genes in their subcutaneous abdominal fat. 
This provides evidence that obesity in CKD also associated 
with inflammation at the cellular level.(13) Positive 
association also found between total body fat, abdominal 
body fat, and markers of inflammation not only in general 
population but also in CKD patients.(11,12)
 High-sensitivity CRP (hs-CRP) is a most frequently 
used marker of inflammation. CRP does not show a 
significant circadian variability in stable condition, and 
its stability in laboratory measurements is comparable to 
serum cholesterol levels. This biomarker also associated 
with  higher  risk  of  cardiovascular  events  and  mortality.
Methods
Study Design and Population Selection
This was an analytic observational study using cross-
sectional design. Ninety patients from outpatient clinics 
and hemodialysis (HD) units at two government and a 
private hospitals in Surabaya and Makasar were recruited 
from May to July 2017. This study was approved by Ethical 
Committee & Law of Universitas Airlangga Hospital with 
No. 093/KEH/2017. 
 Seventy three patients were diagnosed with CKD. 
Seventy one patients were qualified to participate in 
this study since 2 patients were excluded due to acute 
inflammatory conditions. The inclusion criteria were  adult 
CKD patients, aged >21 years old and agreed to participate 
in this study. The diagnosis of CKD was confirmed by 
National Kidney Foundation Kidney Disease Outcomes 
Quality Initiative (NKF K-DOQI) criteria based on Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation (estimated glomerular filtration rate (eGFR) ≤60 
mL/min/1.73 m2, urine albumin >300 mg/day, albumin to 
creatinine ratio (ACR) >250 mg/g for men and >355 mg/g 
for women).  Exclusion criteria were overt infection, fever 
in the last 3 days, signs of infection, acute inflammatory 
disease and malignancy. 
Anthropometric Measurement
Anthropometric measurements, included body weight, 
height, BMI, BFP, skinfold thickness (SKF) of triceps 
and biceps were performed by trained physician. Body 
weight was measured to the nearest 0.1 kg in balance-beam 
scale. Height was measured to the nearest 0.5 cm while 
patients standing erect with their head in plane. BMI was 
calculated using formula of body weight (kg) divided by 
square of height (m2).  SKF was measured using Lange 
skinfold caliper on the left arm or on the arm contrary to 
arteriovenous fistule for patients underwent hemodialysis. 
BFP was calculated using Kwok’s Formula:
(14,15,16) The objective of this study was to assess the 
association between body fat percentage (BFP) with serum 
hs-CRP level in CKD patients. This study compared the 
ability of BFP with widely used body mass index (BMI) 
to predict the value of serum hs-CRP in CKD patients. 
Considering these findings that link body fat with the 
presence of inflammation, we hypothesized that higher 
body fat are associated with elevated serum hs-CRP in CKD 
patients.
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BFP = -27.149 + 6.137(SexB) + 1.120(BMI) + 17.308 log10(Sum 2). 
Notes: SexB, female=2, male=1; Sum 2, triceps + biceps.(17)
Laboratory Parameters
Blood and urine samples were collected early in the 
morning. Measurement of kidney function parameters 
(estimated glomerular filtration rate (eGFR), urine ACR, 
serum creatinine, serum cystatin-C) were performed 
using routine laboratory methods. High-sensitivity CRP 
was measured by Particle enhanced Turbidimetry (Roche 
Diagnostic, California, USA)
Statistical Analysis
Normality test was performed using Shapiro Wilk. For 
normally distributed variables, data were shown as 
mean±SD. For skewed variables, data were shown as 
median and interquartile range (1st quartile-3rd quartile). 
Correlation  between  variables  was  performed  using 
Pearson correlation test. Receiver operating characteristic 
(ROC) curve were plotted using absolute value of BFP 
and hs-CRP value (high hs-CRP >3 mg/L). Optimal cut-off 
was defined as BFP value with highest cumulative value of 
sensitivity and specificity. 
 All testing were two-tailed at the 0.05 significance 
level. The statistical analyses were performed using 
XLSTAT software version 2016.02.28451.
Results
Characteristic of Study Participants
Seventy one patients were evaluated in this study (median 
age 59, 41 male). The baseline characteristics of study 
participants were depicted in Table 1. The median of 
eGFR was 20 mL/minute/1.73 m2.  From anthropometric 
data, it was  shown that the averaged BMI of our subjects 
was 25.8±4.4. Overweight and obesity prevalence were 
42% and  14% respectively. Only 2 (3%) subjects were 
undernourished. The majority of subjects had some 
cardiometabolic diseases, such as 73% have type 2 diabetes 
mellitus, 87% percents have hypertension and 41% have 
congestive heart failure (CHF). 
Comparison of Characteristic between Non-HD and HD 
Patients
The comparison between non-HD and HD patients 
characteristic was depicted in Table 2. There were no 
significant differences in age and sex ratio between non-
HD and HD patients.  There were significant differences 
Characteristic CKD HD and Non-HD(n=71)
Age (years) 59 (53-63)
Sex ratio (M/F) 41/30
eGFR (mL/minute/1.73 m2) 20 (3-39)
Urine ACR 408 (19-2174)
Serum Creatinine (mg/L) 2.9 (1.7-12.7)
Serum Cystatin-C (mg/L) 2.8 (1.7-6.7)
HD, n (%) 26 (37)
Body Fat Percentage (%) 19.1 (16.0-24.0)
Body weight (kg) 67.0 (54.4-76.9)
BMI, (kg/m2) 25.8±4.4
Biceps skinfold (cm) 1.2 (1.0-1.7)
Triceps skinfold (cm) 2.3 (1.6-3.0)
18.5-24.9, n (%) 29 (40.845)
25-29.9, n (%) 30 (42.254)
<18.5, n (%) 2 (2.817)
>=30, n (%) 10 (14.085)
Total Cholesterols (mg/dL) 204 (167-236)
LDL Cholesterols (mg/dL) 122 (49)
HDL Cholesterols (mg/dL) 39 (13)
Type 2 Diabetes, n (%) 54 (76)
Hypertension, n (%) 62 (87)
High SBP, n (%) 26 (37)
High DBP, n (%) 10 (14)
CHF, n (%) 29 (41)
hs-CRP (mg/L) 1.8 (1.1-4.3)
High hs-CRP, n (%) 24 (34)
Kidney Function
Anthropometry
Lipid parameters
Cardiovascular Disease and Risk Factors
BMI Categories
Table 1. Characteristics of study participants.
in kidney function parameters for eGFR, urine ACR, 
serum creatinine, serum cystatin-C between two groups. 
Those were,  eGFR (<0.0001), urine ACR (<0.0001), 
serum creatinine (<0.0001), serum cystatin-C (<0.0001). 
Anthropometry measurement results mostly demostrated no 
significant differences. Those were for body fat percentage, 
body weight, BMI, and biceps skinfold. However, triceps 
skinfold of HD patients was significantly lower than non-HD 
patients (p<0.05). Our study showed that the HD patients 
had significantly higher hs-CRP level than non-HD patients 
(p<0.01). However there was no significant difference of the 
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Characteristic Non HD(n=45)
HD
(n=26) p -value
Age (years) 58.13±5.92 57.62±10.98 0.9
Sex ratio (M/F) 27/18 14/12 0.613
eGFR (ml/minute/1.73 m2) 29 (22-60) 3 (2-4) <0.0001*
Urine ACR 184 (18-803) 1789 (834-3473) <0.0001*
Serum Creatinine (mg/dL) 1.88 (1.29-2.59) 14.14 (11.51-15.95) <0.0001*
Serum Cystatin-C (mg/L) 1.88 (1.28-2.61) 7.42(6.58-7.94) <0.0001*
Body Fat Percentage (%) 20.7±7.2 18.7±7.9 0.205
Body weight (kg) 69 (62.0-78.0) 61.8 (52.6-74.9) 0.11
BMI (kg/m2) 26.31±4.25 25.02±4.59 0.254
Biceps Skinfold  (cm) 1.3 (1.0-1.8) 1.1 (1.0-1.6) 0.586
Triceps Skinfold (cm) 2.4 (2.1-3.1) 1.8 (1.3-2.8) 0.026*
Total Cholesterols (mg/dL) 215 (182-245) 189 (151-206) 0.013*
LDL Cholesterols (mg/dL) 131±54 105±34 0.037*
HDL Cholesterols (mg/dL) 44±15 39±14 0.237
Type 2 Diabetes, n (%) 41 (91) 15 (58) 0.001*
Hypertension, n (%) 39 (87) 26 (100) 0.337
High SBP, n (%) 6 (13) 20 (77) <0.0001*
High DBP, n (%) 4 (9) 6 (23) 0.098
CHF, n (%) 15 (33) 14 (54) 0.09
hs-CRP (mg/L) 1.40 (0.90-3.20) 2.10 (1.65-8.05) 0.010*
High hs-CRP, n (%) 12 (26.67) 12 (46.12) 0.094
* : significant correlation
Kidney Function
Anthropometry
Lipid parameters
Cardiovascular Disease and Risk Factors
Table 2. Comparison of characteristic between non-HD and HD patients.
p -value Correlation Coefficient p -value
Correlation 
Coefficient
BFP 0.025* 0.266 0.006* 0.324
BMI 0.448 0.092 0.117 0.188
Total Cholesterol 0.129 0.182 0.728 0.042
LDL Cholesterol 0.099 -0.197 0.117 -0.188
HDL Cholesterol 0.004* -0.341 0.001* -0.378
Ratio of Total/HDL Cholesterol <0.0001* 0.637 0.004* 0.339
* : significant correlation
hs-CRP log hs-CRP
Parameters
Table 3. Pearson’s matrix of association between BFP and hs-CRP.
proportion of patients with high hs-CRP between non-HD 
and HD patients. 
hs-CRP Concentration in CKD Patients
Positive correlation was found between BFP and hs-CRP 
(r= 0.266; p<0.05) as shown in Table 3. However there was 
no significant correlation between BMI and hs-CRP.
Comparison for BMI and BFP to Predict High hs-CRP
BFP and BMI may predict inflammation in our CKD 
patients with cut off point 18.4% (Figure 1, Figure 2).  The 
BFP value above 18.4% were positively associated with 
high hs-CRP, indicated by significant crude and adjusted 
odd ratio (OR) (4.705 and 5.056 respectively). The crude 
OR of high hs-CRP was also significant for BMI (3.447). 
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Figure 1. ROC curve of BFP and BMI to predict high hs-CRP (p-value= 0.001).
Discussion
Since  there  were  no  significant  differences  in  age,  sex, 
BMI,  BFP,  and  the  prevalence  of  high  hs-CRP  between 
non-HD and HD groups, we combined HD and non-HD 
groups in the sensitivity and specificity analysis of BFP and 
BMI to predict high hs-CPR. In this observational study, we 
demonstrated positive correlation between BFP and hs-CRP 
in CKD populations. 
 CRP   is  an   established   marker  of   systemic 
inflammation in the general population as well as patients 
with CKD. Inflammation plays fundamental role in 
pathophysiology of CKD and has beed linked with 
cardiovascular  disease,  protein  energy  wasting  and 
mortality in CKD patients.(18) Our study showed that the HD 
patients group with significantly lower kidney function had 
significantly higher hs-CRP level than the non HD patients. 
Several studies has shown predictive values of hs-CRP 
in CKD. Persistently elevated hs-CRP level is associated 
with all cause mortality in ESRD. It is also considered as 
a predictor for malnutrition and cardiovascular disease in 
hemodialysis patients.(14) 
 The most prevalent nutritional status in our study was 
overweight (BMI 25-29.9). This was in line with the finding 
of a large cohort study conducted by Herrington, et al., 
which concluded that BMI >25 kg/m2 was associated with 
a progressively increased risk of CKD stages 4-5.(19) Prior 
studies  also  found  high prevalence  of  overweight  and 
obesity in predialysis and CKD patients.(20,21) However, 
our study could not show correlation between BMI and hs-
CRP level. Several literatures have stated that BMI is less 
than ideal metric for obesity in CKD population.(22) Others 
also highlight the limitations of BMI as a reflection of body 
It remained significant after adjusted by age (3.487). The 
area under curve (AUC) of receiver operating characteristic 
(ROC) for BMI was lower than BFP (Table 4).
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Figure 2. Sensitivity and 
specificity of body fat 
percentage for predicting 
high hs-CRP.
Test Value CI 95% Test Value CI 95%
AUC 0.71 (0.592-0.828) 0.637 0.501-0.774
Sensitivity 0.833 (0.634-0.938) 0.583 0.388-0.755
Specificity 0.553 (0.412-0.686) 0.723 0.581-0.831
Odds Ratio (Unadjusted) 4.705 (1.560-14.192) 3.447 1.247-9.530
Odds Ratio (Adjusted by Age) 5.056 (4.343-5.885) 3.487 3.046-3.992
BFP BMI
Table 4. AUC, specificity, sensitivity, and OR (CI 95%) of high hs-CRP value using BFP’s 
optimal cut-off 18.4% and BMI cut-off 27.3 kg/m2.
composition (21), since it is unable to discriminate fat and 
muscle  mass  as  well  as  hydration  status  which  often 
alter in CKD patients.(23,24) Therefore we also included 
BFP as anthropometric parameter other than BMI.
 The correlation between BFP and hs-CRP in this 
study was concordance with previous study which 
demonstrate association between CRP and BFP measured 
by bioimpedance method in non dialysis stage 3-5 CKD 
patients. Inflammatory cytokines in CKD are produced not 
only by lymphocytes, but also by  adipose tissue, which 
becomes dysfunctional in CKD (25) characterized by 
increased hs-CRP production (26). Additionally, this study 
observed that the hs-CRP also correlate negatively with 
HDL cholesterol and positively with total/HDL cholesterol 
ratio. Some previous extensive studies have shown that the 
impaired cholesterol metabolism was strongly correlated 
with increased inflammatory state in CKD patients.(27) 
The cholesterol profile was also correlated well with BMI 
and BFP, although not at the same degree of association 
compared to triglycerides.(27) Therefore theoretically, 
greater BFP and BMI would reflect as a higher cholesterol 
levels. In this study, the total/HDL cholesterol ratio was the 
strongest factor associated with hs-CRP levels compared 
to others lipid parameters as well as anthropometric 
parameters. However, this study failed to observe the 
association between laboratory lipid parameters with either 
BMI and BFP (data not shown).
 We used anthropometry based BFP calculation using 
Kwok’s formula. We assumed that the characteristics of 
subjects in Kwok’s study were similar with our study.(28) 
Anthropometry based BFP  is considered to be a valid 
discriminator for cardiometabolic risk in comparison 
with  dual energy X-ray absorptiometry (DEXA) scan and 
Bioelectrical impedance analysis (BIA) methods, as shown 
by Krachler, et al., in general population.(29) This method 
is cheaper and easier compared to DEXA Scan and BIA. 
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 The finding of this study should be viewed with some 
limitation. The small sample size of this study might not 
reflect accurately the predictive ability of BFP and BMI to 
estimate the value of hs-CRP. Specificity of hs-CRP was 
considered to be low since many factors may influence its 
measurement i.e., diabetes, infection, smoking, chronic 
diseases, sleep disorders, malnutrition, anemia, old age, 
alcohol consumption, CVD, hypertension, vascular access, 
pregnancy, pharmacological therapy, dialysis and CRP gene 
polymorphism, which this study did not estimate in the 
statistical analysis. Additionally, the relatively narrow range 
of BFP and BMI among the study participants may limit the 
ability of statistical analysis to generate prediction model 
for hs-CRP. Therefore, this study could demonstrate some 
degree of association between anthropometric-based BFP 
and hs-CRP but with poor correlation and predictive value.
Another limitation regarding this study is its applicability 
aspect. The relatively poor correlation between BFP and hs-
CRP has limited the usability of the specificity, sensitivity, 
and predictive value generated from this study in the daily 
clinical practice. However, the association of BFP and 
hs-CRP showed in this study might indicate a potential 
relationship between the two variables, particularly when a 
significantly bigger sample size is introduced.
Conclusion
In overall, this study emphasized the need to regularly 
assess nutritional status in CKD using BFP rather than BMI 
alone since it demonstrated better association with hs-CRP 
in our study. It needs further study to evaluate larger and 
more heterogenous samples to explore malnutrition as a risk 
factor for chronic inflammation as well as cardiovascular 
complications in CKD patients.
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